Halozyme Therapeutics
HALO
#1703
Rank
C$17.76 B
Marketcap
C$156.52
Share price
2.73%
Change (1 day)
56.55%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of June 2026 : C$3.67 Billion

According to Halozyme Therapeutics's latest financial reports the company's total assets are C$3.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$3.45 B16.79%
2024-12-31C$2.96 B28.8%
2023-12-31C$2.29 B-8%
2022-12-31C$2.49 B77.53%
2021-12-31C$1.40 B90.35%
2020-12-31C$0.73 B0.05%
2019-12-31C$0.73 B23.24%
2018-12-31C$0.59 B-8.26%
2017-12-31C$0.65 B86.01%
2016-12-31C$0.35 B39.36%
2015-12-31C$0.25 B30.92%
2014-12-31C$0.19 B77.76%
2013-12-31C$0.10 B-19.12%
2012-12-31C$0.13 B100.29%
2011-12-31C$66.88 M-26.74%
2010-12-31C$91.3 M12.48%
2009-12-31C$81.17 M-12.8%
2008-12-31C$93.09 M-9.8%
2007-12-31C$0.10 B92.33%
2006-12-31C$53.66 M124.73%
2005-12-31C$23.87 M21.2%
2004-12-31C$19.7 M2246.62%
2003-12-31C$0.83 M130.55%
2002-12-31C$0.36 M774.97%
2001-12-31C$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$286.45 B 7,700.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$286.55 B 7,703.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$202.71 B 5,420.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$209.85 B 5,615.04%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
C$28.19 B 667.86%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$1.04 B-71.59%๐Ÿ‡บ๐Ÿ‡ธ USA